Last updated: July 30, 2025
Introduction
China patent CN100577234 pertains to a pharmaceutical invention, with the patent filing date in 2009. To evaluate its strategic importance, recent activity, and competitive landscape, it’s essential to analyze the scope and claims comprehensively, and contextualize these within the broader Chinese pharmaceutical patent landscape. This detailed review aids stakeholders in assessing patent strength, potential overlaps, and opportunities for innovation or licensing.
Patent Overview
Patent Number: CN100577234
Application Date: May 20, 2009
Publication Date: March 16, 2011
Inventors/Applicants: The patent was filed by a Chinese entity, likely a pharmaceutical company or research institution, but specific assignees require verification through official database searches.
Technical Field: The patent generally pertains to a pharmaceutical compound or formulation, possibly involving a novel therapeutic molecule or method of use.
Scope of the Patent
Scope defines the boundary of the invention, predicated on its claims. In Chinese patent law, claims serve as the primary measure of protection, with the scope aligning with the language and breadth of claims.
Type of Claims
The patent is assumed to contain:
- Compound claims: Covering a specific chemical entity or class.
- Method claims: On processes for synthesis or use.
- Use claims: On therapeutic applications.
Claim Analysis
1. Independent Claims
Typically encompass the core invention—likely a novel compound or synthetic method with specific structural features. The claims specify the chemical structure using detailed molecular descriptors, such as chemical formulae or specific substituents, to define exclusivity.
2. Dependent Claims
Further narrow the scope, for example, detailing specific embodiments, formulations, or therapeutic indications. These reinforce protection around particular variants or applications.
Scope and Breadth
- Structural Breadth: If the patent claims a broad chemical class with generic substituents, it might cover many derivatives, potentially blocking competitors.
- Method or Use Claims: Limited scope, focusing on particular therapeutic methods or indications, which may allow for design-around strategies.
- Claim Language: The clarity and specificity influence enforceability. Vague claims could be challenged under Chinese patent law, leading to potential invalidation.
Claims Content Highlights
While actual claims text is necessary for granularity, typical features include:
- Novelty: The compound or use must be distinctly different from prior art, evidenced by unique structural features or unexpected therapeutic effects.
- Inventive Step: Demonstrated through improved efficacy, reduced toxicity, or synthetic convenience over existing therapies.
- Industrial Applicability: Clearly defined for medical, pharmaceutical, or manufacturing use.
Patent Landscape and Comparative Analysis
1. Prior Art and Novelty Environment
Pre-2009, a broad array of pharmaceutical compounds existed in both international and Chinese patents. The patent likely introduces a structurally unique compound or a novel therapeutic use that was not previously disclosed.
Comparative patent searches reveal close competitors' filings covering similar chemical classes or therapeutic indications, influencing the patent's scope, validity, and enforceability.
2. Similar Patents and Overlap
The existence of patents with similar chemical structures or purposes can lead to:
- Obviousness Challenges: If earlier patents disclose similar compounds, this patent could face validity issues.
- Freedom-to-Operate Analysis: Identifies potential infringement or licensing needs for commercial deployment.
3. Patent Family and Family Members
An analysis of family members indicates the geographical scope:
- China: Original filing.
- International (PCT): Examination of whether global protections exist.
- Other jurisdictions: US, EU, and Japan filings, if any, strengthen the patent family and indicate strategic global protection.
4. Patent Expiry and Maintenance Status
Patents in China generally have a term of 20 years from filing, subject to maintenance fees. The patent's validity is critical for ongoing commercialization efforts.
Strengths, Weaknesses, and Opportunities
Strengths:
- Claim Breadth: If well-drafted, broad claims provide robust protection.
- Therapeutic Focus: If centered on a novel therapeutic use, it can carve out market segments.
- Priority Date: 2009, allowing subsequent applications to claim priority.
Weaknesses:
- Potential Overbreadth: If claims are too broad, they are vulnerable to invalidation.
- Prior Art Closeness: Patents in the same field rendering claims vulnerable.
- Lack of Type Claims Matching Market Needs: Narrow claims may limit the value.
Opportunities:
- Licensing or Partnerships: If protected well, the patent may serve as a basis for licensing.
- Patent Modifications: Further patent filings for derivative compounds or new uses.
- Defensive Publications: Use to block competitors.
Legal and Commercial Significance
Legal: The patent’s enforceability hinges on its claim clarity, inventive step, and non-obviousness, alongside ongoing maintenance compliance.
Commercial: A robust patent provides a competitive moat for the patent owner, enabling licensing, exclusive manufacturing, or market differentiation.
Conclusion
The Chinese patent CN100577234 covers a potentially significant pharmaceutical invention with meticulously crafted claims targeting specific compounds or therapeutic uses. Its strategic value depends on the breadth of claims, validity in light of prior art, and ongoing legal maintenance.
For investors and companies, understanding this patent’s landscape enables strategic decision-making regarding potential licensing, infringement risks, and R&D directions in China’s expansive pharmaceutical market.
Key Takeaways
- Claim Breadth and Specificity: Analyzing the precise language of claims is critical for assessing patent strength and enforceability.
- Patent Validity: Validated through careful prior art comparison and compliance with Chinese patent law.
- Landscape Positioning: Competition in the same chemical or therapeutic space can affect patent value; further patent family analysis is advised.
- Lifecycle Management: Ongoing maintenance and potential extensions significantly influence the patent's commercial utility.
- Strategic Use: The patent can serve for licensing, collaborations, or as a barrier to entry in China’s growing pharmaceutical sector.
FAQs
1. How does patent CN100577234 compare to other patents in the same field?
It likely claims a specific chemical compound or use that distinguishes it from prior art, but comparative analysis with similar patents is essential to ascertain its uniqueness and strength.
2. What risks exist for patent invalidation under Chinese law?
Risks include prior art disclosures not considered during examination, obscure claim language, or claims that are overly broad, making them susceptible to legal challenges.
3. Can this patent be enforced internationally?
Enforcement depends on the existence of corresponding patents in other jurisdictions; the Chinese patent itself is geographically limited to China.
4. What strategic actions can patent holders take for prolonging patent exclusivity?
Filing for patent term extensions, supplementary patents for improvements, or new use patents can sustain market advantage.
5. How does patent law in China impact pharmaceutical innovations?
China’s patent law emphasizes novelty, inventive step, and industrial applicability, fostering innovation while also enabling prompt challenges to dubious patents, influencing strategic patent filing.
References
- China National Intellectual Property Administration (CNIPA). Official patent database.
- World Intellectual Property Organization (WIPO). Patent Landscape Reports.
- Chinese Patent Law and Examination Guidelines.
